Literature DB >> 8108115

Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion.

J Etiemble1, C Degott, C A Renard, G Fourel, B Shamoon, L Vitvitski-Trépo, T Y Hsu, P Tiollais, C Babinet, M A Buendia.   

Abstract

The high oncogenic efficiency of woodchuck hepatitis virus (WHV) has been correlated with the ability of this virus to provoke insertional activation of myc family genes. To assess the impact of viral integration on liver cell transformation, we have generated transgenic mice carrying the mutated c-myc gene and adjacent viral DNA from a woodchuck tumor, in original configuration. Virtually all mice from two different strains developed hepatocellular carcinoma with a mean latency period of 8-12 months. The c-myc transgene was expressed transiently in neonatal livers, and re-expressed at preneoplastic and neoplastic stages in adult livers. Woodchuck c-myc mRNA driven by the normal P1 and P2 promoters and WHV-specific transcripts encoding viral surface antigens were produced in a strictly co-regulated fashion during development and tumorigenesis, indicating a predominant regulatory influence of the viral enhancer. Furthermore, the activity of the viral enhancer in response to various biological stimuli was apparently modulated by glucose uptake and glucagon/insulin balance in differentiated hepatocytes. In this model, a viral integration event selected from a naturally occurring tumor proved to be determinant for induction of hepatocarcinogenesis, although enforced, liver-specific expression of c-myc was limited to a particular developmental stage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108115

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Marie-Annick Buendia; Christine Neuveut
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

2.  p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53.

Authors:  A Ori; A Zauberman; G Doitsh; N Paran; M Oren; Y Shaul
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

3.  The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter.

Authors:  G Fourel; F Ringeisen; M Flajolet; F Tronche; M Pontoglio; P Tiollais; M A Buendia
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  Woodchuck hepatitis virus enhancer I and enhancer II are both involved in N-myc2 activation in woodchuck liver tumors.

Authors:  M Flajolet; P Tiollais; M A Buendia; G Fourel
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.

Authors:  Drazen B Zimonjic; Veronika Ullmannova-Benson; Valentina M Factor; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  Cancer Genet Cytogenet       Date:  2009-05

6.  Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype.

Authors:  Erin Connolly; Margherita Melegari; Pablo Landgraf; Tatyana Tchaikovskaya; Bud C Tennant; Betty L Slagle; Leslie E Rogler; Mihaela Zavolan; Thomas Tuschl; Charles E Rogler
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

7.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.

Authors:  A de La Coste; B Romagnolo; P Billuart; C A Renard; M A Buendia; O Soubrane; M Fabre; J Chelly; C Beldjord; A Kahn; C Perret
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

8.  Liver cell transformation in chronic HBV infection.

Authors:  Shirine Benhenda; Delphine Cougot; Christine Neuveut; Marie Annick Buendia
Journal:  Viruses       Date:  2009-10-30       Impact factor: 5.818

9.  Molecular mechanisms underlying hepatocellular carcinoma.

Authors:  Philippe Merle; Christian Trepo
Journal:  Viruses       Date:  2009-11-09       Impact factor: 5.048

10.  Radio-deoxynucleoside Analogs used for Imaging tk Expression in a Transgenic Mouse Model of Induced Hepatocellular Carcinoma.

Authors:  Haibin Tian; Xincheng Lu; Hong Guo; David Corn; Joseph Molter; Bingcheng Wang; Guangbin Luo; Zhenghong Lee
Journal:  Theranostics       Date:  2012-06-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.